Can texted videos and a helping hand tame diabetes in immigrant communities?

NCT ID NCT06319703

First seen Mar 29, 2026 · Last updated Jun 22, 2026 · Updated 12 times

Summary

This study tests whether weekly diabetes education videos sent by text message, plus help from a community health worker, can improve blood sugar control in Chinese immigrants with type 2 diabetes. 270 participants in New York City will be randomly assigned to receive the program right away or after a waiting period. The main goal is to see if the program lowers HbA1c levels over 24 weeks.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • NYU Langone Health

    RECRUITING

    New York, New York, 10016, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Diabetes self-management videos and community health worker support

What this could lead to

If successful, this approach could offer a practical, low-cost way to help low-income immigrants better manage their diabetes and lower blood sugar levels.

What could go wrong

This is a relatively small, early-stage study focused on a specific population, so results may not apply broadly. The intervention is behavioral, so improvements may be modest or hard to sustain long-term.

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.